SCHEMBL5580581

SCHEMBL5580581

O=C(O)Cc1cccc(-c2cccc(OC/C=C/c3ccc(-c4ccccc4)cc3)c2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 1/20 0.50
LTB4R2 Q9NPC1 1/20 0.50
CFD P00746 1/20 0.49
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
PPARD Q03181 2/20 0.46
MRGPRX4 Q96LA9 2/20 0.46
NR4A2 P43354 1/20 0.46
GRIN2D O15399 1/20 0.43
GRIN3B O60391 1/20 0.43
GRIN1 Q05586 1/20 0.43
GRIN2A Q12879 1/20 0.43
GRIN2B Q13224 1/20 0.43
GRIN2C Q14957 1/20 0.43
GRIN3A Q8TCU5 1/20 0.43
HDAC4 P56524 1/20 0.43
ABCC4 O15439 1/20 0.43
LMNA P02545 1/20 0.43
GAA P10253 1/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5580588 1.00 LTB4R (0.50) LTB4RLTB4R2CFDNPC1RAB9A
SCHEMBL5580583 0.95 LTB4R (0.54) LTB4RLTB4R2CFDNPC1RAB9A
SCHEMBL5580586 0.95 LTB4R (0.54) LTB4RLTB4R2CFDNPC1RAB9A
SCHEMBL14512212 0.89 NPC1 (0.49) LTB4RLTB4R2CFDNPC1RAB9A
SCHEMBL14539080 0.89 LTB4R (0.57) LTB4RLTB4R2NPC1RAB9APPARD
SCHEMBL5580432 0.88 RXRA (0.46) LTB4RLTB4R2CFDNPC1RAB9A
SCHEMBL5580428 0.88 RXRA (0.46) LTB4RLTB4R2CFDNPC1RAB9A
SCHEMBL5580782 0.85 LTB4R (0.42) LTB4RLTB4R2CFDNPC1RAB9A
SCHEMBL5580785 0.85 LTB4R (0.42) LTB4RLTB4R2CFDNPC1RAB9A
SCHEMBL5580511 0.84 PTGER1 (0.52) LTB4RLTB4R2CFDABCC4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070105959-A1 Cynnamyl alcohol derivative compounds and drugs containing the compounds as active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2007-05-10 US disclosed
US-20070105959-A1 Cynnamyl alcohol derivative compounds and drugs containing the compounds as active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2007-05-10 US disclosed
US-20070105959-A1 Cynnamyl alcohol derivative compounds and drugs containing the compounds as active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2007-05-10 US disclosed
EP-1604971-A1 CINNAMYL ALCOHOL DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2005-12-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070105959-A1 Cynnamyl alcohol derivative compounds and drugs containing the compounds as active ingredient LPL, GPR119, EBP LTB4R 1607/4885LTB4R2 2007/4885CFD 2612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.